Search research articles
Contact Us
Filters
Showing results (21-30 of 55) with videos related to
Page
of 6
Sort By:
JHEP Reports : Innovation in Hepatology
|
August 21, 2023
Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspirates
Samuel C Kim, Jeffrey J Wallin, Yanal Ghosheh, et al.
Gut
|
November 5, 2025
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study
Patrick T F Kennedy, Scott Fung, Maria Buti, et al.
Journal of Viral Hepatitis
|
December 11, 2020
Distinct Hepatitis B and HIV co-infected populations in Canada
Curtis Cooper, Matt Driedger, David Wong, et al.
Journal of Viral Hepatitis
|
September 1, 2022
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B
Kin Seng Liem, Heng Chi, Scott Fung, et al.
Cancer
|
July 17, 2015
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
W Ray Kim, Rohit Loomba, Thomas Berg, et al.
JHEP Reports : Innovation in Hepatology
|
April 1, 2022
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada
Carla Osiowy, Ken Swidinsky, Sarah Haylock-Jacobs, et al.
Gastroenterology
|
December 26, 2013
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B
Scott Fung, Peter Kwan, Milotka Fabri, et al.
Hepatology International
|
March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years
Maria Buti, Scott Fung, Edward Gane, et al.
Journal of Viral Hepatitis
|
March 22, 2021
Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study
Mina S Farag, Scott Fung, Edward Tam, et al.
The Journal of Clinical Investigation
|
January 3, 2023
Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells
Shirin Nkongolo, Deeqa Mahamed, Adrian Kuipery, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 55) with videos related to
Sort By:
Page
of 6
JHEP Reports : Innovation in Hepatology
|
August 21, 2023
Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspirates
Samuel C Kim, Jeffrey J Wallin, Yanal Ghosheh, et al.
Gut
|
November 5, 2025
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study
Patrick T F Kennedy, Scott Fung, Maria Buti, et al.
Journal of Viral Hepatitis
|
December 11, 2020
Distinct Hepatitis B and HIV co-infected populations in Canada
Curtis Cooper, Matt Driedger, David Wong, et al.
Journal of Viral Hepatitis
|
September 1, 2022
Early virologic relapse predicts alanine aminotransferase flares after nucleos(t)ide analogue withdrawal in patients with chronic hepatitis B
Kin Seng Liem, Heng Chi, Scott Fung, et al.
Cancer
|
July 17, 2015
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
W Ray Kim, Rohit Loomba, Thomas Berg, et al.
JHEP Reports : Innovation in Hepatology
|
April 1, 2022
Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada
Carla Osiowy, Ken Swidinsky, Sarah Haylock-Jacobs, et al.
Gastroenterology
|
December 26, 2013
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B
Scott Fung, Peter Kwan, Milotka Fabri, et al.
Hepatology International
|
March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 years
Maria Buti, Scott Fung, Edward Gane, et al.
Journal of Viral Hepatitis
|
March 22, 2021
Effectiveness and Renal Safety of Tenofovir Alafenamide Fumarate among Chronic Hepatitis B Patients: Real-World Study
Mina S Farag, Scott Fung, Edward Tam, et al.
The Journal of Clinical Investigation
|
January 3, 2023
Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells
Shirin Nkongolo, Deeqa Mahamed, Adrian Kuipery, et al.
Page
of 6